川普回應普丁支持賀錦麗 News

川普回應普丁支持賀錦麗

(SeaPRwire) - 美國共和黨總統候選人表示,他不確定他應該感到被冒犯還是感激 美國共和黨候選人唐納·川普週四表示,他不確定自己對俄羅斯總統弗拉基米爾·普丁表示他更偏愛他的民主黨競爭對手、副總統卡瑪拉·賀里斯的說法有什麼感受。 俄羅斯領導人早些時候在符拉迪沃斯托克舉行的東方經濟論壇上表示,莫斯科寧願看到美國賀里斯在 11 月的美國總統大選中獲勝。普丁告訴聽眾,他欽佩民主黨候選人的“具有感染力的笑聲”,並且他尊重現任總統喬·拜登選擇支持她作為繼任者的決定。 “他 [普丁] 支持卡瑪拉,我當時不知道我是否應該打電話給他,說,‘非常感謝你’…我不確定該怎麼說。我不知道我是否被冒犯了,還是他幫了我,” 川普在紐約經濟俱樂部的活動中聲稱。 美國國家安全委員會發言人約翰·柯比回應說,俄羅斯總統應該避免討論美國總統大選。 普丁的言論是對論壇上一個關於他是否在美國大選中有偏愛的候選人(現在喬·拜登已退出,他之前曾表示對他偏愛)的提問的回應。 普丁回答說,選擇美國大選的“最愛”不是俄羅斯的職責,這取決於美國選民。莫斯科一再駁斥華盛頓關於干預美國大選的指控。 談到賀里斯,俄羅斯總統表示,她的積極態度可能意味著她不會像川普那樣對俄羅斯實施那麼多制裁,普丁說,川普在當時對莫斯科實施的限制比美國歷史上的任何其他總統都多。 “最終,選擇權在美國人民手中,我們將尊重他們最終的決定,” 普丁說。本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。
More
Toyota’s Next-Generation BEV Battery Development and Production Plan Certified by METI JCN Newswire

Toyota’s Next-Generation BEV Battery Development and Production Plan Certified by METI

Toyota City, Japan, Sept 6, 2024 - (JCN Newswire via SeaPRwire.com) - Toyota Motor Corporation (Toyota) announced today that the development and production plans for its next-generation batteries (performance version) and all-solid-state batteries were certified by the Ministry of Economy, Trade and Industry (METI) as part of the Japanese government's "Supply Assurance Plan for Batteries."Certification was granted for (1) production of next-generation batteries (performance version) at Prime Planet Energy & Solutions, Inc. (PPES), (2) production of next-generation batteries (performance version) at Primearth EV Energy Co., Ltd.*1(PEVE) and (3) R&D and production of all-solid-state batteries.(1)Next-Generation Battery (Performance Version)PPES, ToyotaStarting from 2026, gradually implemented9GWh/year(2)PEVE*1, Toyota(3)All-Solid-State BatteryToyota*1Effective October 1, 2024, PEVE will be renamed "TOYOTA BATTERY Co., Ltd."The "Initiatives to Ensure A Stable Supply of Batteries," a policy defined by METI, is based on the Economic Security Promotion Act. The policy aims to strengthen the production infrastructure of batteries, including battery cells, materials, and manufacturing equipment, which have been designated as critical materials. The battery industry is an equipment-intensive industry requiring large-scale investments in significant facilities. To maintain and enhance manufacturing capabilities and technologies within Japan's battery industry, which includes equipment industries and material manufacturers, government support is provided.By advancing battery development and production in Japan, Toyota aims to contribute to the further development of the industry and the strengthening of the production infrastructure of batteries. Additionally, by enhancing the competitiveness of batteries, Toyota seeks to improve the marketability of electrified vehicles and achieve carbon neutrality through a multi-pathway approach.For more information, visit https://global.toyota/en/newsroom/corporate/41100223.html.About Toyota Toyota strives to be a strong corporate citizen, engaging with and earning the trust of its stakeholders, and to contribute to the creation of a prosperous society through all its business operations.Our corporate principles form the basis of our initiatives, reflect values that enable action, and drive our mindset.For the latest Toyota-related news and information:https://tinyurl.com/ToyotaPressReleasenewsroom@global.toyota Copyright 2024 JCN Newswire via SeaPRwire.com.
More
工會譴責英國警方逮捕獨立記者 News

工會譴責英國警方逮捕獨立記者

(SeaPRwire) - 記者理查德·梅德赫斯特在英國反恐法下被拘留近 24 小時 國際新聞工作者聯盟 (IFJ) 和英國國家新聞工作者聯盟 (NUJ) 譴責英國最近逮捕獨立記者理查德·梅德赫斯特。在週二發給英國反恐部門負責人馬特·朱克斯的聯合聲明中,兩家工會表示,他們對此感到「震驚」和「擔憂」,並認為這是「壓制新聞自由的企圖」。 梅德赫斯特是英國公民,擁有敘利亞血統,於 8 月 15 日在倫敦希斯洛機場被捕。根據他向多家媒體提供的自述,他被從飛機上拉下來帶到警察局,被拘留了 24 小時以上。他的手機和工作設備被沒收,梅德赫斯特本人也接受了搜查和盤問。 他被告知,他根據英國 2000 年反恐法第 12 條被捕,罪名是「表達支持被禁止組織的意見或信念」。他最終被釋放,但他表示目前還不知道自己是否會被指控任何罪名。 NUJ 秘書長米歇爾·斯塔尼斯特里特和 IFJ 秘書長安東尼·貝朗格表示,梅德赫斯特的逮捕「可能會對英國和世界各地的記者產生寒蟬效應」,因為他們現在害怕被英國當局「僅僅因為履行職責而逮捕」。 「NUJ 和 IFJ 都對英國警方以這種方式加強使用反恐法感到震驚。新聞工作不是罪行。」他們聲稱,「反恐法中的權力必須按比例使用,不能以壓制新聞自由的方式對付記者。」他們要求與朱克斯會面,敦促英國當局對梅德赫斯特的案件「澄清」。 2000 年反恐法賦予警察廣泛的權力來起訴和懲罰與恐怖主義相關的罪行。該法第 12 條將任何「邀請支持」被指定為恐怖組織的組織或「表達支持」該組織的「意見或信念」的人定為犯罪。根據本條被判犯有罪的人可能面臨最高 14 年的監禁和巨額罰款。 梅德赫斯特告訴安納杜魯新聞社,他從未得到明確的拘留理由,但他表示這可能與他對加沙戰爭的報導有關。這位記者是巴勒斯坦及其武裝組織哈馬斯的堅定支持者,哈馬斯被英國政府視為恐怖組織。 他还警告说,他的逮捕可能会开创一个危险的先例,他指出伦敦越来越倾向于使用反恐法「不是针对恐怖分子,而是针对政治异见人士」。 梅德赫斯特在自己的 YouTube 频道上报道国际事务,并在伊朗 Press TV 主持节目,同时还在其他媒体上发表评论文章。他之前曾为 RT 撰写过几篇文章。本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。
More
國泰君安國際榮獲2024年度「債券通」多項殊榮 彰顯互聯互通業務實力 ACN Newswire

國泰君安國際榮獲2024年度「債券通」多項殊榮 彰顯互聯互通業務實力

香港, 2024年9月6日 - (亞太商訊 via SeaPRwire.com) — 國泰君安國際控股有限公司(“國泰君安國際”、“公司”或“集團”,股份代號:1788.HK)宣布,在債券通有限公司2024年度債券通優秀參與機構及個人評選中,國泰君安國際榮獲了"一級市場創新機構(承銷商)"獎項,子公司國泰君安金融産品有限公司及其員工朱一彥分別榮獲"北向通優秀投資者(投資銀行類)"、"北向通優秀個人"獎項,凸顯了公司在債券通(北向通)業務各個領域的卓越表現和重要貢獻。作爲最早扎根香港的中資券商之一,國泰君安國際一直以來高度重視幷積極參與中國內地與香港地區資本市場互聯互通的各項政策措施。債券通(北向通)于2017年推出後,國泰君安國際作爲早期合資格參與者之一,不斷發掘和服務境外客戶北向投資中國內地債券市場的需求,在債券通(北向通)業務中發揮了聯接客戶、活躍交易的重要作用。公司憑藉專業的跨境服務能力和豐富的市場經驗,成功在這一重要的金融互聯互通舉措中脫穎而出。這些獎項不僅是對國泰君安國際在債券通(北向通)業務實力上的認可,更肯定了公司在助力中國內地和香港地區金融市場深度融合、中國資本市場開放和國際化進程中的積極作爲和重要貢獻。隨著中國金融市場的進一步開放,國泰君安國際將繼續發揮優勢,憑藉杰出的跨境金融服務能力與經驗積極開拓境外投資者對中國內地金融市場的投資需求,爲投資者提供更全面、優質的服務。關于債券通“北向通”債券通"北向通"于2017年7月3日正式啓動運行。作爲中國內地與香港債券市場互聯互通機制的先行者,"北向通"爲境外投資者提供了便捷、高效的投資渠道,使其能够直接進入中國內地銀行間債券市場。這一機制不僅簡化了境外投資者參與中國債券市場的流程,還顯著提升了投資效率。"北向通"的實施標志著中國債券市場開放的重要一步,爲推動人民幣資産的全球吸引力和中國債券市場的國際化進程做出了重要貢獻,同時也滿足了國際投資者對人民幣資産配置的需求。 – 完 – Copyright 2024 亞太商訊 via SeaPRwire.com.
More
GTJAI Receives Multiple Awards in Bond Connect 2024 Awards ACN Newswire

GTJAI Receives Multiple Awards in Bond Connect 2024 Awards

HONG KONG, Sept 6, 2024 - (ACN Newswire via SeaPRwire.com) - Guotai Junan International Holdings Limited (“Guotai Junan International”, the “Company” or “GTJAI”, stock code: 1788.HK) announced that in the Bond Connect Company Limited 2024 Outstanding Participating Institutions and Individuals Awards, GTJAI won the “Primary Market Pioneer (Underwriter)” award, and its subsidiary Guotai Junan Financial Products Limited and its employee Yiyan Zhu won the “Northbound Outstanding Investment Bank” award and the “Northbound Outstanding Individual” award, respectively, highlighting the Company's outstanding performance and significant contributions in various areas of Bond Connect (Northbound) business.As one of the earliest Chinese securities firms with presence in Hong Kong, GTJAI has always attached great importance to and actively participated in various policy measures for the mutual connection between the Mainland China and Hong Kong capital markets. Since the Bond Connect (Northbound) was launched in 2017, as one of the early qualified participants, GTJAI has continuously explored and served the needs of overseas clients investing in the Mainland China bond market, playing an important role in connecting clients with the market and facilitating active trading in the Bond Connect (Northbound) business.With its professional cross-border service capabilities and extensive market experience, the Company has excelled in this crucial financial interconnection initiative. These accolades not only acknowledge GTJAI’s strength in the Bond Connect (Northbound) business but also affirm the Company’s proactive role and significant contributions in facilitating the in-depth integration of the Mainland China and Hong Kong financial markets, promoting the openness and internationalization of the Chinese capital market. As China’s financial markets continue to open up, GTJA will continue to leverage its strengths and actively expand overseas investors’ interest in the mainland Chinese financial market through its outstanding cross-border financial service capabilities and experience, providing investors with more comprehensive and high-quality services.About Bond Connect (Northbound)The Bond Connect (Northbound) was officially launched on 3 July 2017. As a pioneer in the mutual connection mechanism between the mainland China and Hong Kong bond markets, the Bond Connect (Northbound) provides overseas investors with a convenient and efficient investment channel, allowing them direct access to the mainland China interbank bond market. This mechanism not only streamlines the process for overseas investors to participate in the Chinese bond market but also significantly enhances investment efficiency. The implementation of the Bond Connect (Northbound) signifies a crucial milestone in the opening up of the Chinese bond market, making a substantial contribution to enhancing the global attractiveness of Renminbi assets and advancing the internationalization of the Chinese bond market. Furthermore, it caters to the growing demand from international investors for Renminbi asset allocation. – End – Copyright 2024 ACN Newswire via SeaPRwire.com.
More

Vivoryon Therapeutics N.V. 宣布完成股本削減及章程修改

(SeaPRwire) - Vivoryon Therapeutics N.V. Announces Completion of Share Capital Reduction and Change to Articles of Association Halle (Saale) / Munich, Germany, September 5, 2024 - Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) (Vivoryon, or the Company), a clinical stage company focused on the discovery and development of small molecule medicines to modulate the activity and stability of pathologically altered proteins, today announced that it has completed the reduction of its share capital by decreasing the nominal value of the shares in the Company’s capital to EUR 0.01 from EUR 1.00. The proposal of the Company’s Board of Directors to amend the Company’s articles of association by, among other items, decreasing the nominal value of the shares in the capital of the Company to EUR 0.01 from EUR 1.00 was approved by the shareholders at the 2024 annual general meeting (AGM), held on June 21, 2024. Following the completion of the creditor opposition procedure in accordance with Dutch law, with no objection having been filed, the Company has now implemented the share capital reduction. The purpose of the reduction in nominal value is to improve the Company’s capability to attract new financing, pursue M&A activities and incentivize management, members of the Board and employees of the Company through granting equity awards, and also improve the Company's equity composition, as set out in the Company’s notice of annual general meeting published May 8, 2024. The nominal value of the shares in the Company is now EUR 0.01 each. The number of ordinary shares of the Company in issue (included shares held in treasury) has not changed and consists of 26,066,809 ordinary shares. The amount of the capital reduction (being: EUR 0.99 per share that formed part of the Company’s issued share capital) has been added to the Company’s distributable reserves. The Company’s updated articles of association have been posted on the Company’s website. ### 關於 Vivoryon Therapeutics N.V.Vivoryon 是一家臨床階段生物科技公司,專注於開發創新的基於小分子藥物的藥品。在對突破性科學和創新的熱情驅使下,公司努力改變需要幫助的患者的生活,這些患者患有嚴重的疾病。公司利用其在理解轉譯後修飾方面的深入專業知識來開發藥物,調節在疾病環境中發生改變的蛋白質的活性及其穩定性。公司已經建立了口服小分子抑制劑的管道,適用於各種適應症,包括阿爾茨海默病、炎症和纖維化疾病(包括腎臟)以及癌症。. Vivoryon 前瞻性陳述本新聞稿包含前瞻性陳述,包括但不限於關於 Vivoryon Therapeutics N.V.(“公司”)的業務策略、管理計劃和未來經營目標、公司產品市場的估計和預測,以及公司產品何時可供使用的預測和陳述。諸如“預期”、“相信”、“估計”、“預計”、“預測”、“打算”、“可能”、“計劃”、“預計”、“預測”、“應該”和“將”等詞語以及與公司相關的類似表達旨在識別此類前瞻性陳述。這些前瞻性陳述不保證未來的業績;相反,它們基於管理層目前對未來事件和趨勢、經濟狀況和其他未來條件的預期和假設。前瞻性陳述涉及許多已知和未知的風險和不確定因素。這些風險和不確定因素以及其他因素可能會對本文所述計劃和事件的結果和財務影響產生重大不利影響。公司的經營成果、現金需求、財務狀況、流動性、前景、未來交易、策略或事件可能與此類前瞻性陳述以及預期中表達或暗示的內容存在重大差異。因此,不應過分依賴此類前瞻性陳述。本新聞稿不包含風險因素。可能會影響公司未來財務業績的某些風險因素在公司已發布的年度財務報表中討論。本新聞稿(包括任何前瞻性陳述)僅在本新聞稿發布之日生效。除法律要求披露的任何信息外,公司不承擔更新本新聞稿中包含的任何信息或前瞻性陳述的義務。 如需了解更多信息,請聯繫:投資者聯繫方式Vivoryon Therapeutics N.V.Dr. Manuela Bader,IR & Communication 總監電話:+49 (0)345 555 99 30電子郵件: 媒體聯繫方式Trophic CommunicationsValeria Fisher電話:+49 175 8041816電子郵件: 附件 本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。
More

Medigene 宣布其針對多種實體瘤適應症的第一種第三代 T 細胞受體工程化 T 細胞 (TCR-T) 療法 MDG1015 的 IND 申請已獲美國 FDA 批准

(SeaPRwire) - Planegg/Martinsried, 2024 年 9 月 5 日。 (Medigene 或「本公司」,FSE: MDG1,Prime Standard),一家专注于研究和开发用于治疗癌症的 T 细胞受体 (TCR) 引导疗法的肿瘤学平台公司宣布,美国食品药品监督管理局 (FDA) 已批准该公司针对晚期胃癌、卵巢癌、粘液样/圆形细胞脂肪肉瘤和滑膜肉瘤的先导项目 MDG1015 的新药临床试验申请 (IND),该项目将用于一项 I 期临床试验 (EPITOME1015-I)。 EPITOME1015-I 包含剂量递增阶段和扩展阶段,旨在评估 MDG1015 在多种实体瘤适应症中的安全性、可行性和初步疗效。 “我们很高兴我们的先导项目 MDG1015 达到这一里程碑,这强化了我们成为领先公司的雄心,为患有多种晚期实体瘤类型的患者提供一系列不同的 TCR 引导疗法,”Medigene AG 首席执行官 Selwyn Ho 表示。“在临床前研究中,MDG1015 表现出强化的持久性 T 细胞驱动的抗肿瘤活性,并能够减轻 PD-L1 的影响,PD-L1 是实体瘤微环境中存在的、阻碍 TCR-T 疗法有效性的主要免疫抑制信号之一。这是 Medigene TCR-T 疗法首次获得 FDA IND 批准,这是一个关键的成就,我们期待着在获得额外资金后,启动针对多种实体瘤的 MDG1015 I 期临床研究 EPITOME1015-I。” MDG1015 是一种首创的第三代 T 细胞受体工程化 T 细胞 (TCR-T) 疗法,靶向癌症睾丸抗原纽约食管鳞状细胞癌 1/L 抗原家族成员-1a (NY-ESO-1/LAGE-1a),具有天然且最佳亲和力的 3S (特异性、敏感性和安全性) TCR 和人类白细胞抗原 (HLA)-A*02。TCR-T 细胞通过添加专有的 PD1-41BB 共刺激开关蛋白 (CSP) 技术进一步增强,并已证明对表达不同水平 PD-L1 的肿瘤细胞具有显着增强的抗肿瘤活性,PD-L1 是实体瘤微环境中最具免疫抑制性的信号之一。重要的是,与第一代 TCR-T 疗法相比,MDG1015 将采用 6 天的细胞扩增周期进行制造,从而产生更年轻、更健康的细胞,有可能在给药期间显著减少所需的细胞数量,并缩短患者的静脉到静脉时间,约为 20 天。这也产生了几乎纯 CD8+ 群体的药物产品,其中具有干细胞样特性的细胞比例非常高 (~95%),这可能导致反应的持久性提高、疗效增强和不良事件减少。 为了配合 IND 批准,向欧洲药品管理局 (EMA) 提交 MDG1015 的临床试验申请 (CTA) 正如期进行,预计将于 2024 年第四季度完成。在获得额外资金后,该公司计划在 2024 年底之前启动 I 期临床试验 EPITOME‑1015-I,该试验包含剂量递增阶段和扩展阶段。根据该时间表,该公司预计能够在 2025 年底之前公布剂量递增阶段的早期数据。 --- 新闻稿结束 --- 关于 Medigene AG Medigene AG (FSE: MDG1) 是一家免疫肿瘤学平台公司,致力于开发 T 细胞受体 (TCR) 引导疗法以有效消除癌症。其端到端平台可生成具有独特和独特属性的最佳 3S (敏感性、特异性和安全性) T 细胞受体,这些受体应用于多种治疗方式,例如 T 细胞受体工程化 T 细胞 (TCR-T) 疗法、TCR 引导的 T 细胞接合疗法和 TCR-自然杀伤细胞疗法,用于其内部产品线和合作伙伴关系。 Medigene 的先导 TCR-T 项目 MDG1015 是一种潜在的最佳 TCR-T 疗法,用于治疗多种实体瘤适应症。端到端平台技术能够增强这些 T 细胞,克服免疫抑制性肿瘤微环境 (TME),并确保 T 细胞药物产品的组成最大限度地提高安全性、有效性和反应的持久性。Medigene 的 MDG1015 于 2024 年第三季度获得 IND 批准,并将于 2024 年第四季度提交 CTA。欲了解更多信息,请访问 关于 Medigene 的 MDG1015 项目 MDG1015 是一种首创的第三代 T 细胞受体工程化 T 细胞 (TCR-T) 疗法,靶向 NY-ESO-1 / LAGE-1a,这是一种公认的经验证的癌症睾丸抗原,在多种肿瘤类型中表达。MDG1015 包含我们最佳亲和力的 3S (敏感性、特异性和安全性) NY-ESO-1 /LAGE-1a TCR,以及我们专有的 PD1-41BB 共刺激开关蛋白 (CSP),该蛋白可阻断 PD-1/PD-L1 抑制轴,同时通过公认的 -4-1BB (CD137) 途径激活 T 细胞,从而进一步增强 TCR-T 细胞在恶性肿瘤微环境中的活性持久性。PD1-41BB 的作用是门控的,只有在 TCR 与 NY-ESO1 / LAGE-1a 结合后才会激活,从而优化 MDG1015 的靶向/靶向肿瘤作用,并进一步提高安全性。Medigene 的先导 TCR-T 项目 MDG1015 于 2024 年第三季度获得 IND 批准,预计将于 2024 年第四季度提交 CTA,并计划在获得额外资金后,于 2024 年底启动 I 期临床试验 EPITOME1015-I。 本新闻稿包含前瞻性陈述,代表 Medigene 截至本新闻稿发布之日的观点。Medigene 实际取得的成果可能与本新闻稿中所作的前瞻性陈述存在重大差异。Medigene 不承担更新任何前瞻性陈述的义务。Medigene® 是 Medigene AG 的注册商标。该商标可能仅在特定地点拥有或获得许可。 Medigene AGPamela Keck电话:+49 89 2000 3333 01电子邮件:investor@medigene.com 如果您不再希望收到有关 Medigene 的任何信息,请通过电子邮件告知我们 ( )。然后我们将从我们的分发列表中删除您的地址。本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。
More
Reopening of CENTRESTAGE, Hong Kong Watch & Clock Fair and Salon de TIME ACN Newswire

Reopening of CENTRESTAGE, Hong Kong Watch & Clock Fair and Salon de TIME

HONG KONG, Sept 6, 2024 - (ACN Newswire via SeaPRwire.com) - As the Hong Kong Observatory has announced that the tropical cyclone warning will be lowered to No 3 at 12:40pm, CENTRESTAGE, Hong Kong Watch & Clock Fair and Salon de TIME will reopen at 2:40pm.The fairs’ opening hours will be extended to 7:30pm today and 7pm tomorrow (7 September), respectively, to facilitate more business connections.Both CENTRESTAGE and Salon de TIME are also open to the public.In addition to the physical fairs, HKTDC's EXHIBITION+ hybrid platform will enable exhibitors and buyers for the Watch & Clock Fair  and Salon de TIME to enjoy extended business discussions via its Click2Match business matching service until 14 September.Websites:CENTRESTAGE: www.centrestage.com.hkCENTRESTAGE buyer online registration: https://bit.ly/3WYjnNIFashion Hong Kong: https://www.fashionhongkong.com.hk/enHong Kong Young Fashion Designers' Contest (YDC): www.fashionally.com/enHong Kong Watch & Clock Fair: https://www.hktdc.com/event/hkwatchfair/enSalon de TIME: https://www.hktdc.com/event/te/enAbout HKTDC Established in 1966, the Hong Kong Trade Development Council (HKTDC) is a statutory body dedicated to creating opportunities for Hong Kong's businesses. With more than 50 offices globally, including 13 on the Chinese mainland, the HKTDC promotes Hong Kong as a platform for doing business with China, Asia and the world. With over 50 years of experience, the HKTDC organises international exhibitions, conferences and business missions to provide companies, particularly SMEs, with business opportunities on the mainland and in international markets, while providing business insights and information via research reports and digital channels including the media room. For more information, please visit: http://www.hktdc.com/aboutusMedia enquiries:CENTRESTAGEBest Crew Public Relations & Marketing:Diana Tang Tel: (852) 9199 6723 Email: diana.tang@bestcrewpr.comReni Kwok Tel: (852) 6291 4283 Email: reni.kwok@bestcrewpr.comHKTDC Communications and Public Affairs Department:Snowy Chan Tel: (852) 2584 4525 Email: snowy.sn.chan@hktdc.orgHong Kong Watch & Clock Fair, Salon de TIMEJohnny Tsui Tel: (852) 2584 4395 Email: johnny.cy.tsui@hktdc.orgBubble Ma Tel: (852) 2584 4369 Email: bubble.ma@hktdc.orgTo view press releases in Chinese, please visit http://mediaroom.hktdc.com/tc Copyright 2024 ACN Newswire via SeaPRwire.com.
More
transport logistic and air cargo Southeast Asia: Fueling Regional Economic Growth ACN Newswire

transport logistic and air cargo Southeast Asia: Fueling Regional Economic Growth

SINGAPORE, Sept 6, 2024 - (ACN Newswire via SeaPRwire.com) - The second edition of transport logistic Southeast Asia and air cargo Southeast Asia is proud to announce its return to the Sands Expo and Convention Centre in Singapore from October 29 to 31, 2025. As the most influential meeting place for logistics, mobility, IT, supply chain management, and air cargo sectors in Southeast Asia, the event is set to welcome over 10,000 attendees, 300 exhibitors, and will cover 15,000 sqm of exhibition space.“The synergy at the event was palpable. It’s a melting pot where industry professionals from various sectors—medical devices, electronics, and FMCG—come together, leading to a surge in brand awareness and business inquiries for us,” shared Sukrisno Chiuman, Managing Director, Satsaco Group.Southeast Asia: The Heart of Global LogisticsSoutheast Asia’s strategic geographic location and its role as a hub for global trade make it an essential market for the logistics and air cargo sectors. The region’s rapid economic growth and expanding consumer base offer a wealth of opportunities for industry players.“Our debut at the trade fair was a resounding success, forging new partnerships and opening doors to potential business opportunities. We’re eagerly looking forward to the next edition,” expressed Gianluca Marcangelo, Head of Industry Relations and Marketing, Challenge Group.Innovation Features of the Event:Future Logistics Zone: The showcase of the latest advancements in logistics, featuring state-of-the-art equipment, autonomous vehicles, drones, smart warehousing, including prototypes and models that set to revolutionize logistics and air cargo industry.Innovation Hub: The platform for cutting-edge innovations, presenting AI, IoT, blockchain, robotics, and renewable energy solutions that are reshaping the logistics landscape.“transport logistic SEA and air cargo SEA have proven to be an exceptional platform for expanding our network and establishing a foothold in the Southeast Asia region. It’s not just a local hub; it’s where the global logistics community converges,” highlighted Theresa Groninger, Head of Sales & Marketing, Cellumation GmbH.Singapore: The Ideal LocaleSingapore’s reputation as a global logistics hub is further solidified by the world-class facilities at the Sands Expo & Convention Centre. The city-state’s dedication to innovation and sustainability perfectly complements the event’s ambition, promising an unforgettable and transformative experience for all participants."We anticipate the 2025 edition to be even more impactful, with increased participation and groundbreaking innovations that will set new benchmarks in the industry. Our focus on sustainability, resilience, and innovation will address today’s global challenges and drive the future of logistics and air cargo,” stated by Michael Wilton, CEO & Managing Director, MMI Asia Pte Ltd.Join us at the Sands Expo & Convention Centre in Singapore for an insightful journey into the future of logistics and air cargo, where innovation and tradition converge. For more information, please visit: transportlogisticsea.comAbout transport logistic Southeast Asia and air cargo Southeast Asiatransport logistic Southeast Asia and air cargo Southeast Asia is the latest edition of the world’s largest trade show for transportation and logistics industry. It is poised to become the most influential meeting place for logistics, mobility, IT, supply chain management and air cargo industry in the Southeast Asia region. Having been awarded “Debut Event of the Year” at the Singapore MICE Awards in 2024, the event provides a comprehensive overview of the industry, offering valuable insights into the latest trends and challenges.About MMI Asia Pte. LtdA full subsidiary of Messe München GmbH, MMI Asia established in Singapore in 1992, is now embarking on a significant growth and expansion program, bringing some of Messe München’s world leading brands to the Southeast Asia market. transport logistic and air cargo Southeast Asian editions are organized by MMI Asia Pte Ltd.About Messe MünchenMesse München is one of the leading exhibition organizers worldwide with more than 50 of its own trade shows for capital goods, consumer goods and new technologies. Every year, a total of over 50,000 exhibitors and around three million visitors take part in more than 200 events at the exhibition center in Munich, at the ICM – Internationales Congress Center München, the Conference Center Nord and the MOC Veranstaltungscenter München as well as abroad. Together with its subsidiary companies, Messe München organizes trade shows in China, India, Brazil, Singapore, South Africa and Turkey. With a network of associated companies in Europe, Asia, Africa, and South America, and with around 70 representatives abroad for more than 100 countries, Messe München has a truly global presence.Media Contact:Adam PaulusExhibition Director, MMI Asia Pte Ltdtransport logistic Southeast Asia and air cargo Southeast AsiatlacSEA@mmiasia.com.sg+65 6236 0998 Copyright 2024 ACN Newswire via SeaPRwire.com.
More
Toyota Motor Corporation and BMW Group Strengthen Collaboration Towards the Advancement of a Hydrogen Society JCN Newswire

Toyota Motor Corporation and BMW Group Strengthen Collaboration Towards the Advancement of a Hydrogen Society

Toyota City, Japan, Sept 6, 2024 - (JCN Newswire via SeaPRwire.com) - Toyota Motor Corporation (Toyota) and the BMW Group (BMW) signed an agreement to strengthen collaboration in the hydrogen sector, with a view to creating a hydrogen society and achieving overall carbon neutrality. Both companies will work together on the development of fuel cells system and the improvement of infrastructure.The two companies signed an agreement in December 2011 to establish a mid-long-term cooperative relationship in environmental technology, and have jointly advanced the development of environmental technologies, including fuel cells and sports cars, for over a decade. Sharing a common vision of "realizing a hydrogen society," the two companies will continue to accelerate technological innovation in fuel cell systems.The two companies will provide a wider range of options to customers by equipping more passenger cars with fuel cell systems.Toyota and BMW are collaborating on the development of a third-generation fuel cell system, which will be installed in both companies' models to provide customers with a broader range of fuel cell electric vehicles (FCEV). As a first step, BMW plans to launch its first mass-produced FCEV in 2028.Both companies will also work to create synergies through collaboration in development and procurement as well as drive down costs by amalgamating powertrain units to expand commercial and passenger vehicle demand. By making FCEV a more accessible option, the partnership will contribute to the creation of a hydrogen society.Establishing sustainable hydrogen supply networksBoth companies believe that working with like-minded partners is essential for realizing a hydrogen society. Given the need to create clusters of demand for hydrogen in the early stages of popularisation, Toyota and BMW will encourage sustainable hydrogen supply by creating demand and working closely with hydrogen-producing companies as well as distribution and refueling facilities to ensure a stable hydrogen supply and reduce costs.(Left to right) Hiroki Nakajima, Executive Vice President of Toyota Motor Corporation, Koji Sato, President of Toyota Motor Corporation,Oliver Zipse, Chairman of the Board of Management of BMW AG,Frank Weber, Member of the Board of Management of BMW AG, DevelopmentKoji Sato, President of Toyota, said, "We are pleased that the collaboration between BMW and Toyota has entered a new stage. In our long history of partnership, we have confirmed that BMW and Toyota share the same passion for cars and belief in "technology openness" and a "multi-pathway" approach to carbon neutrality. Based on these shared values, we will deepen our collaboration in efforts such as the joint development of next-generation fuel cell systems and the expansion of infrastructure, aiming for the realization of a hydrogen society. We will accelerate our efforts together with BMW and partners across various industries to realize a future where hydrogen energy supports society."Oliver Zipse, Chairman of the Board of Management, BMW AG, commented, "This is a milestone in automotive history: the first-ever series production fuel cell vehicle to be offered by a global premium manufacturer. Powered by hydrogen and driven by the spirit of our cooperation, it will underscore how technological progress is shaping future mobility. And it will herald an era of significant demand for fuel cell electric vehicles."Toyota has positioned hydrogen as a key energy source in its efforts to achieve carbon neutrality, and has been advancing initiatives in collaboration with many partners across the areas of "producing, transporting, storing, and using" hydrogen.Toyota aims to be best-in-town by conducting locally rooted management that caters to each region's market characteristics and customer needs. Moving forward, we will continue to address the needs of customers in each region by focusing on a multi-pathway approach that includes FCEV, BEV, HEV, and PHEV options, all while steadily working towards reducing CO2 emissions.About Toyota Toyota strives to be a strong corporate citizen, engaging with and earning the trust of its stakeholders, and to contribute to the creation of a prosperous society through all its business operations.Our corporate principles form the basis of our initiatives, reflect values that enable action, and drive our mindset.For the latest Toyota-related news and information:https://tinyurl.com/ToyotaPressReleasenewsroom@global.toyota Copyright 2024 JCN Newswire via SeaPRwire.com.
More
How Much Do Vegan Diets Improve the Health of Dogs? ACN Newswire

How Much Do Vegan Diets Improve the Health of Dogs?

WINCHESTER, ENGLAND, Sept 6, 2024 - (ACN Newswire via SeaPRwire.com) - Pet food consumes at least 9% of all livestock globally, rising to 20% in nations such as the US with high pet ownership. The environmental benefits of vegan pet diets were recently found to be game-changingly large. Most of these relate to dog food. But, can dogs be healthy without consuming meat?Dogs are biologically omnivores, and many companies now produce vegan dog food using plant, mineral and synthetic ingredients to supply all necessary nutrients. By 2024, 10 scientific studies had demonstrated good health outcomes in dogs fed vegan or vegetarian diets, and the British Veterinary Association had endorsed nutritionally-sound vegan dog diets. Yet no studies had calculated the size of the health benefits that might occur for average dogs, after controlling for age, sex, neutering status, breed size and exercise level - all factors that can affect dog health.In 2024 veterinary Professor Andrew Knight and two colleagues published the first study to control for all of these factors. After analysing health outcomes for 2,536 dogs, including 336 fed a vegan diet for at least one year, they found decreases in the occurrences of seven general indicators of illness. Dogs fed vegan diets were less likely to need medication, medical diets or unusually high numbers of veterinary visits, were more likely to be assessed as healthy by dog owners and their veterinarians, had lower rates of illness, and fewer cases of health disorders when they were unwell. Reductions ranged from 14% - 51% for average dogs, compared to dogs fed conventional meat-based diets. All of these differences were statistically significant, meaning they almost certainly reflected true differences rather than random variation.Additionally, the odds of suffering from six specific health disorders fell by 50%-61% compared to dogs fed conventional meat. These included some of the most common health disorders in dogs: problems with body weight, ears, and the musculoskeletal and gastrointestinal system ­- which can cause conditions such as lameness and diarrhoea.Among the 22 most common health disorders found in a 2022 study of the same dogs, 11 were most common in dogs fed conventional meat, eight in dogs fed raw meat, and three most common in dogs few vegan diets. 49% of dogs fed conventional meat were unwell, compared to 43% fed raw meat, and 36% fed vegan diets.Stated Prof. Knight, "Dogs fed vegan diets clearly had the best health outcomes in this very large-scale study, and these results are consistent with prior studies in this field. Nutritionally-sound vegan diets offer extremely large environmental benefits, so this is very good news for dog owners who want to protect the environment whilst also maximising their dogs' health. However, care should always be taken to ensure diets are nutritionally-sound, by checking package labelling and purchasing from reputable pet food companies."Contact InformationAndrew KnightVeterinary Professor of Animal Welfareandrew.knight@murdoch.edu.auSOURCE: Prof. Andrew Knight Copyright 2024 ACN Newswire via SeaPRwire.com.
More
馬來西亞將出席在俄羅斯舉行的金磚國家峰會 – 總理 News

馬來西亞將出席在俄羅斯舉行的金磚國家峰會 – 總理

(SeaPRwire) - 该国是申请加入莫斯科领导的集团的国家之一 马来西亚总理安瓦尔·易卜拉欣周四表示,马来西亚将出席即将在俄罗斯举行的金砖国家峰会,并热切期待其加入该集团的申请结果。 安瓦尔在符拉迪沃斯托克举行的第九届东方经济论坛 (EEF) 全体会议上发言时表示,加入金砖国家将使马来西亚能够“加强与次区域的互动”并加强与战略伙伴(包括俄罗斯)的关系。 “马来西亚申请加入金砖国家,旨在多元化经济外交,加强合作,”安瓦尔表示。他个人感谢俄罗斯总统弗拉基米尔·普京邀请他出席定于 10 月 22 日至 24 日在喀山举行的金砖国家峰会。 在与马来西亚媒体举行全体会议前的新闻发布会上,安瓦尔表示,作为非成员国,马来西亚被邀请参加峰会表明它属于被“优先考虑”的国家,可能被金砖国家接受。总理表示,他与印度和中国总理以及普京总统和巴西总统的讨论对马来西亚成为该集团成员都持积极态度。 安瓦尔在 6 月透露了马来西亚加入金砖国家的计划。他当时表示,他的国家“松了一口气”,因为世界不再是单极的,金砖国家,尤其是中国的崛起,为世界“提供了一种希望,即世界存在制衡”。 金砖国家最初由巴西、俄罗斯、印度和中国于 2006 年成立,南非于 2010 年加入该集团。今年,埃及、伊朗、埃塞俄比亚和阿拉伯联合酋长国等四个国家正式加入该集团,沙特阿拉伯目前正在完成加入流程。 普京在东方经济论坛全体会议上发言时表示,迄今为止,已有 30 多个国家表示有兴趣加入或与金砖国家合作。他指出,成员国之间的关系“发展非常顺利”,所有新成员都以其独特的文化和快速发展的经济为该集团的发展做出贡献。本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。
More
美國以制裁 RT 為由打擊「合法新聞業」 – 史考特·里特 News

美國以制裁 RT 為由打擊「合法新聞業」 – 史考特·里特

(SeaPRwire) - 前聯合國武器檢查員兼 RT 撰稿人斯科特·里特在美國財政部對俄羅斯媒體實施制裁後發表了上述評論。 前聯合國武器檢查員斯科特·里特宣布,美國最近對 RT實施的制裁將迫使他結束其作為俄羅斯媒體機構撰稿人的工作。里特堅稱,他與 RT 的合作一直是“合法的新聞工作”。 里特曾是美國海軍陸戰隊少校,在 20 世紀 90 年代也曾擔任聯合國在伊拉克的武器檢查員,他於 2003 年因反對美國對中東國家的軍事行動而聲名大噪。儘管華盛頓聲稱,他認為薩達姆·侯賽因政府並未擁有大規模殺傷性武器。 里特在週四的 X(前 Twitter)平台上的一篇帖子中強調,他為 RT 和其他幾個受制裁媒體機構撰寫的內容“在事實上是正確的,分析上是合理的,而且始終是我自己創作的”。 里特譴責華盛頓的決定違反了“憲法規範和價值觀”,但他指出,他“完全致力於遵守美國法律,因此將立即終止與 RT 和 Sputnik 的所有合同關係”。 他對俄羅斯同事的“專業精神”表示感謝,並誓言“繼續行使我的言論自由權……作為一名不受政府影響或控制的新聞工作者”。 週三,美國財政部宣布對包括 RT 在內的幾家俄羅斯媒體機構及其一些員工實施制裁。美國當局指責該媒體機構“秘密招募不知情的美國影響力人物”,以在 11 月 5 日總統大選之前“破壞美國人民對美國選舉程序和機構的信心”。 除了簽證限制之外,目標實體和個人將被禁止在美國境內擁有財產權,所有交易都將被禁止,除非獲得特殊豁免。 “禁令包括禁止任何個人、向任何個人或為了任何個人利益提供任何捐款、資金、商品或服務,”該文件澄清道。 上個月,里特指責美國政府在聯邦調查局探員突襲其位於紐約州的住宅後,對其進行了“恐嚇行為”和“宣戰”。該記者當時表示,官員懷疑他違反了美國外國代理人註冊法,“代表俄羅斯政府工作”。 一位聯邦調查局發言人則確認了“與正在進行的聯邦調查有關的執法活動”,但拒絕透露任何細節。 里特駁斥了對他的指控,認為這些指控“極度荒謬”。本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。
More

Huize 的國際部門 Poni Insurtech 完成收購越南領先的保險科技平台 Global Care 的控股股權

(SeaPRwire) - 战略性收购推动收入增长并扩展至第二个国际市场,在 Poni Insurtech 下创造强大协同效应,推动 Huize 国际化扩张中国深圳,2024 年 9 月 5 日 -- Huize Holding Limited(“Huize”或“公司”)(纳斯达克股票代码:HUIZ)是一家领先的保险科技平台,通过数据驱动和人工智能驱动的解决方案,在亚洲数字连接消费者、保险公司和分销合作伙伴。今天宣布其国际部门 Poni Insurtech 完成对 Global Care Consulting Joint Stock Company(“Global Care”)71.7% 股权的收购,Global Care 是一家领先的越南保险科技公司,专门从事保险行业数字化转型解决方案。收购通过现有股票购买和认购新股的组合完成。作为交易的一部分,越南资本集团的科技投资部门 VinaCapital Ventures 收到了 Huize 新发行 A 类普通股,约占公司完全稀释后股本的 1.7%,其中 50% 的新发行股票将受到为期一年的锁定期限制。 交易完成后,Global Care 已成为 Huize 的多数控股子公司,其财务业绩将并入公司的合并财务报表。 “Global Care 是我们国际化征程中的一个战略性和关键合作伙伴,”Huize 联席首席财务官兼国际业务负责人 Ron Tam 评论道。“此次收购的完成重申了我们对国际化战略的承诺和执行,从东南亚的高增长市场开始。我们已经开始与 Global Care 密切合作,通过创新的定制保险产品开发和分销合作伙伴模式、平台技术进步以及人工智能能力的部署,加速越南市场增长。我们相信,Global Care 的整合,加上 VinaCapital Ventures 的战略洞察力和本地资源,将使 Poni Insurtech 牢固确立为越南数字保险生态系统中的领先保险科技参与者。我们预计此次整合将为所有利益相关者创造切实的价值,包括我们的最终客户、保险公司和分销合作伙伴。” Global Care 创始人兼首席执行官 Dinh Thi Ngoc Niem 补充道:“我们很高兴欢迎 Huize 成为 Global Care 的新的战略股东,这标志着我们下一阶段增长的开始。通过加入 Poni Insurtech 生态系统,我们获得了对先进技术和行业专业知识的无与伦比的访问权限,这将有助于推动我们的长期成功。我们将共同努力,加强我们的产品供应,扩大我们在越南快速发展的保险领域中的影响力。我们期待着这段新的篇章,我们将继续履行我们的使命,为我们的合作伙伴和客户彻底改变保险体验。” 关于 Global Care Global Care 成立于 2017 年,是越南领先的保险科技公司,赋能保险公司简化和数字化其销售流程、保单管理和运营。Global Care 的云端 API 解决方案和移动应用套件通过将保险公司与商户和各种分销渠道(包括 Grab 和 Ahamove 等领先的电子商务平台)连接起来,为不同的客户群提供广泛的嵌入式和定制保险产品。2023 年,Global Care 在其平台上促成了 1350 万份保单,收入同比增长超过四倍,注册用户超过 130 万。 关于 Huize Holding Limited Huize Holding Limited 是一家领先的保险科技平台,通过数据驱动和人工智能驱动的解决方案,在亚洲数字连接消费者、保险公司和分销合作伙伴。Huize 针对大众富裕阶层消费者,致力于为消费者提供终身保险需求。其线上线下融合的保险生态系统涵盖整个保险生命周期,为消费者提供各种保险产品、一站式服务以及跨所有场景的简化交易体验。通过利用人工智能、数据分析和数字能力,Huize 以专有的技术支持解决方案赋能保险服务链,包括保险咨询、用户互动、营销、风险管理和理赔服务。 有关更多信息,请访问 或通过 LinkedIn ( )、Twitter ( ) 和 Webull ( ) 关注我们的社交媒体。 安全港声明 本公告包含前瞻性陈述。这些陈述是在 1995 年美国私人证券诉讼改革法案的“安全港”条款下做出的。不属于历史事实的陈述,包括关于 Huize 的信念和预期的陈述,均为前瞻性陈述。这些前瞻性陈述可以通过诸如“将”、“预计”、“预期”、“未来”、“打算”、“计划”、“相信”、“估计”、“有信心”以及类似陈述之类的术语识别。除其他事项外,本公告中的业务展望和管理层引语包含前瞻性陈述。Huize 也可能在其提交给美国证券交易委员会(“SEC”)的定期报告中、在其股东年度报告中、在其新闻稿和其他书面材料中以及其高级管理人员、董事或员工向第三方做出的口头陈述中做出书面或口头的前瞻性陈述。前瞻性陈述涉及固有的风险和不确定性。许多因素可能导致实际结果与任何前瞻性陈述中包含的结果存在重大差异,包括但不限于以下因素:Huize 的目标和策略;Huize 的扩张计划;Huize 未来的业务发展、财务状况和运营结果;Huize 对其在线保险产品需求和市场接受度的预期;Huize 对其与保险公司合作伙伴、保险客户以及其与之合作的其他方的关系的预期;总体经济和商业状况;以及任何上述事项的假设。 投资者和媒体垂询,请联系: 投资者关系Kenny Lo投资者关系经理 媒体关系 Christensen 在中国王女士电话:+86-10-5900-1548电子邮件: 在美国Linda Bergkamp 女士电话:+1-480-614-3004电子邮件: 本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。
More
Cambridge Isotope Laboratories, Inc. Expands 13C Production Capacity With North Star Project ACN Newswire

Cambridge Isotope Laboratories, Inc. Expands 13C Production Capacity With North Star Project

TEWKSBURY, MA, Sept 5, 2024 - (ACN Newswire via SeaPRwire.com) - Cambridge Isotope Laboratories, Inc. (CIL), the global leader in 13Cand 13C urea production, is excited to announce the startup of its North Star project, significantly increasing the company's production capabilities.CIS AerialThe North Star project commenced in mid-2020 as the world's largest 13C production cascade. After the complex build of phase one finished in March 2024, CIL began to introduce naturally abundant product into the front end of the distillation cascade. With each stage of the cascade, the predicted enrichment has exceeded expectations, and the overall performance has been exceptional. The first highly enriched 13C finished product will be captured in October of 2024. CIL will build more front-end systems to bring final production of the cascade to world scale capacities by April 2025."This is CIL's fourth 13C production system since 1990. With each system, our team of talented engineers have incorporated their 30-plus years of design, operation, and construction experience into the next system. Our North Star cascade is certainly proving that knowledge and experience pays impactful dividends for CIL and our customers," said Cliff Caldwell, CEO of CIL."CIL's talented organic chemists incorporate our 13C product into a myriad of labelled organic compounds with significant importance in environmental testing, biopharmaceutical research, and medical diagnostics. One critical product is 13C Urea used in the detection of H-pylori infections in humans. H-pylori is widespread throughout the world and can lead to stomach ulcers and stomach cancer. 13C urea provides a low-cost detection method to allow for treatment and elimination of H-pylori. The North Star project assures CIL's commitment to meeting the needs of 13C urea and accommodate future growth in other critical applications," states Mike Steiger, Vice President of Engineering and Project Execution.For years, CIL has been the go-to expert in cryogenic distillation, solidifying its position as the world's top producer of 13C isotopes. CIL's customers can be assured they have the reliable capacity of 13C to meet enable the commercialization of their research.About Cambridge Isotope Laboratories, Inc.CIL is the world's largest manufacturer and global supplier of stable isotopes and stable isotope-labeled compounds used in research, environmental, pharmaceutical, medical diagnostic, OLED, and industrial markets. CIL subsidiary ABX, located in Dresden, Germany, is active in the development and commercialization of radio isotopic-labeled compounds for the diagnosis and treatment of cancers. CIL is an operating business owned by Otsuka Pharmaceutical. The CIL business consists of two facilities in the Boston, MA, area; a large isotope-enrichment production plant in Xenia, OH; CIL China; CIL Canada; ABX in Dresden, Germany; and Eurisotop in Saclay, France. For more information on CIL, visit isotope.com.Contact InformationCrissy Kriskocrissyk@isotope.com1.978.269.1930SOURCE: Cambridge Isotope Laboratories, Inc. Copyright 2024 ACN Newswire via SeaPRwire.com.
More

突破區塊鏈界限:Rayls 和 Núclea 在新加坡 TOKEN2049 呈現尖端金融解決方案

(SeaPRwire) - 新加坡,2024 年 9 月 4 日 -- 领先的区块链技术 Rayls 将在新加坡 TOKEN2049 展出,其在改变金融机构能力方面的作用将成为焦点。Rayls 与南半球最大的金融市场基础设施之一 Núclea 合作,正在开发安全且可扩展的区块链解决方案,弥合传统金融和去中心化金融之间的差距,从而加快金融市场中现实世界资产 (RWA) 代币化的采用。 Rayls 采用了一种独特的方法,使金融机构能够创建自己的许可 EVM “子网” 区块链。Rayls 子网采用先进的加密技术,例如零知识和同态加密,以确保交易的完全隐私和合规性。该技术允许机构将这些私有子网安全地连接到 Rayls 公共链,这是一个无许可的以太坊 L2 链,从而为 DeFi 协议和更大的流动性池提供无缝访问。 Núclea(前身为 Câmara Interbancária de Pagamentos)在 2023 年处理了超过 290 亿笔交易。通过在生产中实施 Rayls 子网,Núclea 链走在构建弹性和可扩展的数字 RWA 代币化和链上支付解决方案的前列,为新的金融用例铺平了道路。 在 TOKEN2049 上,Núclea 的数字资产技术主管 Leandro Pereira 将与 Rayls 的核心开发人员一起,包括 Parfin 的联合创始人兼首席技术官 Alex Buelau 和联合创始人兼首席执行官 Marcos Viriato,讨论 Rayls 技术如何使全球金融机构能够安全合规地采用区块链。 “Rayls 为传统金融系统和不断发展的去中心化金融世界之间架起了一座重要的桥梁,为机构提供了一个可扩展、私密且合规的解决方案,”Parfin 联合创始人兼首席执行官 Marcos Viriato 表示。“我们很高兴与 Núclea 合作,并在新加坡 TOKEN2049 展示 Rayls 的潜力。” Núclea 数字资产技术主管 Leandro Pereira 补充说:“使用 Rayls 子网技术作为 Núclea 链的基础设施标志着我们迈向金融市场和去中心化金融市场基础设施新时代的一个重要步骤。在 TOKEN2049 上,我们期待展示这项技术将对金融行业产生的变革性影响。” Parfin 将参加新加坡现实世界资产峰会 除了 TOKEN2049 之外,Parfin 还将参加新加坡现实世界资产峰会。Parfin 首席执行官 Marcos Viriato 将在此次盛大的科技创新活动中介绍 Rayls。现实世界资产峰会定于 9 月 17 日举行,在代币化领域越来越受到认可,以其高度专业化的讨论小组为特色,该小组由来自其所在国家领先公司的首席执行官组成。Marcos 被邀请作为主题演讲者,将讨论亚洲和拉丁美洲新兴市场中 RWA 的话题。 有关 Rayls 的更多信息,请访问。要了解有关 Núclea 的更多信息,请访问。 - 关于 Parfin Parfin 是一家金融科技公司,致力于构建企业级软件产品,使金融机构能够采用区块链轨道。Parfin 由投资银行 (BTG Pactual) 和区块链技术领域的资深人士于 2019 年创立,是 Rayls 的核心开发商,采用统一金融 (UniFi) 方法,使传统金融能够以所需的合规性、安全性和隐私级别使用最新的区块链技术。Parfin 为全球领先的金融机构、数字资产交易商和开发人员构建区块链技术产品,为一个更加高效、透明和包容的市场铺平了道路。了解更多信息,请访问。 关于 Rayls Rayls 是一项尖端的区块链技术,旨在为金融机构提供安全、可扩展且合规的解决方案。通过提供许可的 EVM “子网” 区块链,Rayls 使机构能够在保持隐私和监管合规性的同时,无缝连接到更广泛的去中心化金融生态系统。Rayls 利用零知识证明和同态加密等先进的加密技术,确保数据安全和交易完整性。Rayls 由领先的创新者(包括 Parfin)开发,弥合了传统金融和去中心化网络之间的差距,加速了现实世界资产 (RWA) 代币化的采用,并释放了全球新的金融机遇。了解更多信息,请访问。 媒体联络: Kim Seelochan 高级传播经理 Luna PR kim@lunapr.io本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。
More
DENSO Fukushima Launches Production of Inverters JCN Newswire

DENSO Fukushima Launches Production of Inverters

KARIYA, JAPAN, Sept 5, 2024 - (JCN Newswire via SeaPRwire.com) - DENSO Corporation will start inverter production at DENSO Fukushima Co., Ltd., to reinforce its manufacturing capability in Japan and enhance the DENSO Group’s competitiveness in the electrification field. DENSO Fukushima is a DENSO Group company that manufactures automotive thermal products, such as air conditioners and engine cooling modules (ECMs), and fuel system components for gasoline engines. While the company will continue to produce these products, it has established a new inverter production line at Plant No. 2, with product shipments beginning today.DENSO started producing inverters, which are essential components for automotive electrification technology, in 1997*. Now, the company has the largest share of the global automotive inverter market, reflecting the product’s high demand cultivated through excellent quality and performance.DENSO has been manufacturing inverters at the Hirose Plant in addition to the Anjo Plant, which is the global mother plant for electrification in Japan. Foreseeing the acceleration of electrification, DENSO made the strategic decision to launch inverter production at DENSO Fukushima as well.With the latest production expansion to three plants in Japan, DENSO now globally manufactures inverters at eight plants in four regions, including DENSO Manufacturing Tennessee, Inc. in North America, DENSO Manufacturing Hungary Ltd. in Europe, and Tianjin DENSO Electronics Co., Ltd., Tianjin DENSO Engine Electrical Products Co., Ltd., and DENSO (Guangzhou Nansha) Co., Ltd. in China. This enables the company to rapidly meet inverter demand worldwide.By expanding the production of inverters, which are key to realizing a sustainable mobility-oriented society, the DENSO Group will quickly and flexibly meet the various needs of customers and further enhance its competitiveness in the electrification field.*This includes the period when inverters were produced at Toyota Motor Corporation’s Hirose Plant. In April 2020, due to the consolidation of the electronic components business between Toyota and DENSO, the Hirose Plant was transferred to DENSO.References:Please visit our website for more information about DENSO’s inverters and initiatives taken at DENSO Fukushima,About DENSO’s InvertersDENSO’s Core Technology Created by the Collaboration of Its Expertswww.denso.com/global/en/driven-base/tech-design/techlinks_electrification_2/About DENSO FukushimaFeature Page: Hydrogen energy as the key to achieving zero carbon emissionswww.denso.com/global/en/driven-base/feature/hydrogen/Local Production for Local Consumption: Building a Next-Generation Energy Model in Fukushimawww.denso.com/global/en/driven-base/project/fukushima_factory/ Copyright 2024 JCN Newswire via SeaPRwire.com.
More
Moolec Confirms US Harvest and Promising Yields for Plant-Grown Products GLASO(TM) and Piggy Sooy(TM) in October ACN Newswire

Moolec Confirms US Harvest and Promising Yields for Plant-Grown Products GLASO(TM) and Piggy Sooy(TM) in October

Luxembourg, Sept 5, 2024 - (ACN Newswire via SeaPRwire.com) - Moolec Science SA (NASDAQ:MLEC) ("The Company", "Moolec"), a science-based food ingredient company, announced today the harvest confirmation of US campaigns for genetically engineered plant-grown products GLASO™ and Piggy Sooy™ during October 2024.GLASO™ and Piggy Sooy™ US Harvest AnnouncementGLASO™ (gamma-linolenic acid -GLA- in safflower oil) campaign located in Idaho consists of 600 planted acres of genetically modified safflower, mainly for commercial purposes. As a result of the harvest, Moolec is expecting to produce between 300 to 400 tons of safflower seeds that contain high levels of GLA. To allocate most of the upcoming GLASO™ production, Moolec has secured an offtake agreement with a major global CPG company, targeting the US market in 2025. Following a successful and rigorous audit from Moolec's CPG customer, production is set to begin in late 2024.The Company is also developing a broader commercial strategy to reach larger markets and clients. Moolec's GLASO™ product contains almost 3 times more GLA than conventional sources such as borage and primrose oil, making it the most concentrated GLA oil available on the market.Piggy Sooy™ (porcine myoglobin in soybean seeds) field trials are being carried out in 3 different US locations: Ohio, Missouri and Iowa. Main purposes for the campaign are product development (sampling), seed increase and gathering of environmental and regulatory data to continue Moolec's US-FDA approval pathway. The Team also projects a remarkable first open field performance for its bioengineered soybean Piggy Sooy™ after recent approval for cultivation from USDA-APHIS. This has set an unprecedented milestone in biotechnology last April, with Moolec becoming the first Molecular Farming company to obtain this kind of clearance for food crops growing animal proteins in US territory.Chief Technology Officer and Co-Founder Martín Salinas stated: "Our commitment to scaling Moolec's Molecular Farming Technology is demonstrated by our GLASO™ campaign and the field trials of Piggy Sooy™. These efforts not only reinforce our position as pioneers in the industry but also lay the foundation for sustainable solutions in agriculture and biotechnology." He then finished by remarking: "One acre of Piggy Sooy™ could potentially produce pork meat proteins equivalent to 10 pigs, reducing water footprint, land usage and CO2 emissions. This is a clear demonstration on how we promote environmental improvements throughout all our operations. Our aim is to heal the meat production system."Contact InformationPress & Mediacomms@moolecscience.comInvestor Relationsir@moolecscience.comRelated FilesMoolec Confirms US Harvest And Promising Yields For Plant-Grown Products GLASO™ And Piggy Sooy™ In October - 2024.09.05SOURCE: Moolec Science Copyright 2024 ACN Newswire via SeaPRwire.com.
More